4043
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Tokuyama Corporation is a diversified industrial group operating across five main business segments: chemicals, cement, electronic advanced materials, life sciences, and environmental businesses. In chemicals, the company manufactures and sells caustic soda, soda ash, vinyl chloride monomer, and propylene oxide. The cement segment produces cement, ready-mixed concrete, and solidifying agents, with operations in Japan and New Caledonia. For electronic advanced materials, the group produces polycrystalline silicon, dry silica, tetrachlorosilane, and high-purity isopropyl alcohol for semiconductor applications. The life sciences segment offers medical diagnostic systems, in vitro diagnostic reagents, dental equipment, and pharmaceutical intermediates. The environmental business focuses on ion exchange membranes and gypsum board recycling. Key subsidiaries include Sun Arrow Chemical, MBL Materials, and Tokuyama Dental. The company serves markets in Japan, Asia, and Europe, with manufacturing and sales entities in Vietnam, China, Singapore, and Germany.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Chemicals Homepage tokuyama.co.jp
Sector Basic Materials IR page tokuyama.co.jp
Tags
industrial chemicals, cement, semiconductor materials, in vitro diagnostics, dental equipment, ion exchange membranes, polycrystalline silicon, soda ash, vinyl chloride, pharmaceutical intermediates, Sun Arrow Chemical, Tokuyama Soda Sales, Hiroshima Tokuyama Ready-Mixed Concrete, Tokuyama Nouvelle Caledonie S.A., Tokyo Tokuyama Concrete, Tokuyama M-Tech, Tokuyama Trading, TOKUYAMA VIETNAM CO. LTD., Tokuyama Chemical (Zhejiang) Co. Ltd., Taiwan Tokuyama Co. Ltd., Tokuyama Singapore Pte. Ltd., Formosa Tokuyama Precision Chemical Co. Ltd., STAC Co. Ltd., TD Power Material, Han-Tok Chemical, A&T Co. Ltd., MBL Materials, Institute of Medical and Biological Sciences, MBL Shenzhen Biotech Co. Ltd., Tokuyama Dental, Aiyin Tokuyama Medical Device Trading (Shanghai) Co. Ltd., MBL Beijing Biotech Co. Ltd., Tokuyama Dental Italy S.r.l., Tokuyama Dental Deutschland GmbH, Tokuyama Dental America Inc., Tokuyama Chiyoda Gypsum, ASTOM Co. Ltd., Excelshannon Co. Ltd., Tomitech Co. Ltd., Tokuyama Korea Co. Ltd., Tokuyama (Shanghai) Management Co. Ltd., Shunan System Industry Co. Ltd., Tokuyama Marine & Land Transport Co. Ltd., Kyoei Oil Co. Ltd., Shunan Bulk Terminal Co. Ltd., Tokuyama Taiwan Co. Ltd., ASM Co. Ltd., OCI Tokuyama Semiconductor Materials Sdn. Bhd., Quartz Tech Tokuyama Co. Ltd., Tokuyama Polypro Co. Ltd., West Japan Regicoat Co. Ltd., Figaro Giken Co. Ltd.
Press page tokuyama.co.jp/news

Metrics

Valuation  
Market cap ¥ 290.011B
Market cap (USD) $ 1.813B
P/E 14.41
PEG 0.43
P/BV 0.94
P/S 0.80
P/OCF 6.54
P/FCF 22.41
Dividend yield 3.0%
Turnover / mcap —
Returns  
ROE 7.8%
ROI 5.6%
ROIC 5.8%
Profit margin 6.4%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 33.4%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 46
Quality score 5.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 349.476B 343.073B 341.99B 351.79B 293.83B 302.407B 316.096B 324.661B 308.061B 299.106B 307.115B 302.085B 287.33B 258.632B
Net profit 22.205B 23.388B 17.751B 9.364B 28B 24.534B 19.937B 34.279B 19.698B 52.165B -100.563B -65.349B 10.218B -37.916B
Free cash flow 21.874B 29.77B 24.237B -43.716B -5.901B 19.514B 32.658B 21.766B 46.359B 3.319B 15.764B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 3.738K 2.788K 2.714K 2.105K 1.719K 2.792K 2.093K 2.613K 3.385K 538.12 — 338.02 338.02 —
Price performance 12m 0.34 0.03 0.29 0.22 -0.38 0.33 -0.2 -0.23 5.29 — — 0 — —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 73.9B 79.7B 80.4B 72.9B 70.9B 78.2B 92.1B 87.1B 81.5B 82.7B
↳ YoY growth +7.8% +7.7% +0.9% -9.2% -2.8% +10.3% +17.7% -5.4% -6.4% +1.4%
↳ 5y CAGR +0.7% +1.1% +2.9% +1.6% +2.3% +3.1%
Borrowings, current (JPY) 17.4B 18.2B 17B 19.2B 10.7B 21.3B 3.9B 21.5B 9.47B 37.5B
Borrowings, non-current (JPY) 195B 120B 109B 94.3B 82.8B 83B 133B 78.3B 94.6B 117B
Bonds payable (JPY) 34.4B — — — — 15B 15B 15B 35B 35B
Lease liabilities (JPY) 2.36B 2.16B 2.53B 2.9B 4.88B 4.98B 5.22B 6.06B 6.57B 7.07B
Cash and deposits (JPY) 122B 57.2B 68.6B 81.5B 83.7B 83.1B 68.1B 48.7B 75.5B 47.2B
Intangible assets (JPY) 4.79B 2.77B 1.97B 1.66B 1.88B 2.68B 3.47B 3.46B 4.21B 63.2B
Net debt (borrowings + leases - cash) (JPY) 93.1B 82.7B 60.4B 34.8B 14.8B 26.1B 74.4B 57.1B 35.1B 115B
Cash flow detail
Operating cash flow (JPY) 20B 61.9B 38.5B 52.4B 43.3B 26B -11.8B 55.8B 52.4B 51B
Purchases of property, plant and equipment (JPY) -16.7B -15.5B -16.8B -19.7B -23.8B -31.9B -31.9B -31.6B -22.6B -29.1B
Change in receivables (cash effect) (JPY) -7.74B -5.86B 928M 7.34B -2.12B -6.8B -13.5B 3.71B 5.26B 2.22B
Change in inventories (cash effect) (JPY) 824M -6.46B -4.07B -1.27B 2.28B -15.7B -25.4B 8.83B 2.43B -184M
Change in payables (cash effect) (JPY) 3.1B 11.3B -1.09B -4.39B -533M 8.54B 561M -1.48B -2.07B -5.18B
Dividends paid (cash effect) (JPY) 0.00 -1.45B -3.12B -4.16B -4.86B -5.03B -5.04B -5.04B -6.84B -7.92B
Interest paid (cash effect) (JPY) -4.25B -3.78B -2.53B -1.71B -1.53B -1.39B -1.54B -1.36B -1.17B -1.77B
Income taxes paid (cash effect) (JPY) -18.1B 2.06B -5.12B -5.45B -4.75B -4.49B -4.61B -2.25B -4.68B -5.12B
Operating cash flow before change in receivables (JPY) 27.8B 67.7B 37.6B 45B 45.4B 32.8B 1.73B 52.1B 47.1B 48.8B
Free cash flow (OCF - PPE - intangibles) (JPY) 3.32B 46.4B 21.8B 32.7B 19.5B -5.9B -43.7B 24.2B 29.8B 21.9B
Income detail
Research and development expense (JPY) 7.51B 7.9B 8.05B 9.19B 10.9B 12.6B 13.6B 14.5B 16.1B 17.7B
↳ 5y CAGR +5.0% +11.0% +11.5% +12.4% +11.8% +10.3%
Total comprehensive income (JPY) 54.6B 27.4B 31.3B 21.3B 30.5B 31.2B 10B 25.8B 19.3B 30.4B
Comprehensive income to owners (JPY) 53.4B 21.7B 30.6B 20.2B 29.7B 30.8B 10B 25.6B 19.9B 29.5B
Provision for credit losses (JPY) -28M -6M -49M -12M 0.00 7M -1M 23M -6M -19M
Credit cost ratio (credit losses / average receivables) (%) 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Segments
Cement · Segment revenue (JPY) — — 92.4B 87.3B 90.9B 50.4B 58.5B 67.2B 64.7B 66.9B
↳ YoY growth -5.5% +4.1% -44.6% +16.2% +14.8% -3.7% +3.4%
Cement · Segment operating income (JPY) — — 3.2B 3.84B 4.58B -1.91B -3.72B 6.71B 7.45B 9.54B
Chemicals · Segment revenue (JPY) — — 98.4B 93.7B 85.5B 101B 116B 116B 115B 106B
↳ YoY growth -4.7% -8.8% +18.7% +14.6% -0.6% -0.5% -7.6%
Chemicals · Segment operating income (JPY) — — 16.9B 15.4B 14.1B 14.2B 6.89B 11.5B 10.8B 9.7B
Eco Business · Segment revenue (JPY) — — — — 9.58B 10.3B 13.8B 7.39B 5.22B 6.13B
↳ YoY growth +7.6% +34.3% -46.6% -29.4% +17.5%
Eco Business · Segment operating income (JPY) — — — — -368M -468M 46M -102M 52M 655M
Electronic And Advanced Materials · Segment revenue (JPY) — — — — — — 91.6B 78B 87.1B 91.7B
↳ YoY growth -14.9% +11.7% +5.3%
Electronic And Advanced Materials · Segment operating income (JPY) — — — — — — 7.01B 3.34B 9.58B 15.7B
Electronic Materials · Segment revenue (JPY) — — — — 61.9B 75B 91.6B — — —
↳ YoY growth +21.2% +22.1%
Electronic Materials · Segment operating income (JPY) — — — — 7.1B 7.23B 7.01B — — —
Life And Amenity · Segment revenue (JPY) — — 55.3B 56.3B 45.9B — — — — —
↳ YoY growth +1.9% -18.4%
Life And Amenity · Segment operating income (JPY) — — 3.24B 2.89B 3.11B — — — — —
Life Science · Segment revenue (JPY) — — — — 28.7B 33.6B 37.6B 41.4B 42B 49.4B
↳ YoY growth +17.1% +11.9% +10.3% +1.3% +17.7%
Life Science · Segment operating income (JPY) — — — — 3.5B 6.04B 7.38B 8.48B 7.82B 7.83B
Specialty Products · Segment revenue (JPY) — — 59.7B 54.5B 57.8B — — — — —
↳ YoY growth -8.7% +6.1%
Specialty Products · Segment operating income (JPY) — — 9.93B 7.06B 6.57B — — — — —
Reported Jun 26, 2017 Jun 25, 2018 Jun 25, 2020 Jun 25, 2020 Jun 27, 2022 Jun 27, 2022 Jun 26, 2024 Jun 26, 2024 Jun 25, 2025 Jun 19, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Tokuyama Corporation (ticker 4043), listed in Japan.

ETFs Holding Tokuyama Corporation

ETF Weight in ETF Shares Market value As of
AVDV 0.18% 1,457,400 $ 34.053M Nov 16, 2026
DISV 0.13% 274,700 $ 6.631M Nov 12, 2026
DFIS 0.09% 204,800 $ 4.944M Nov 12, 2026
DXIV 0.04% 4,000 $ 96.56K Nov 12, 2026
AVDS 0.04% 6,300 $ 147.201K Nov 16, 2026
DFIC 0.02% 150,200 $ 3.626M Nov 12, 2026
DFAX 0.01% 68,060 $ 1.643M Nov 12, 2026
DFAI 0.01% 61,600 $ 1.487M Nov 12, 2026
AVDE 0.00% 7,200 $ 168.23K Nov 16, 2026